Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Meet Kathy: 100-Mile Rider in 2017 Answer to Cancer

    On June 10, 2017, Kathy will ride for her husband, T.J.

    April 20, 2017| Katherine McCluskey
  • PIMCO: Supporting a Future Immune to Cancer

    PIMCO sponsors the 5K Family Fun Run/Walk of the 2nd annual Answer to Cancer and fields an…

    April 12, 2017| Katherine McCluskey
  • AACR17 Update: Checkpoint Immunotherapy Clinical Trials in Melanoma and Lung Cancer

    In-depth analysis of long-term clinical trial data provides important insights for doctors treating…

    April 6, 2017| Arthur N. Brodsky, PhD
  • AACR17 Update: Checkpoints, Vaccines, and the Power of Prediction

    Day 3 at AACR17 highlighted the importance of immune memory and personalized approaches…

    April 3, 2017| Arthur N. Brodsky, PhD
  • AACR17 Update: CAR T Cells, Regulatory T Cells, and the Future of Immunotherapy

    Day two addressed several strategies to improve immunotherapy’s precision and effectiveness

    April 2, 2017| Arthur N. Brodsky, PhD
  • AACR17 Update: Taking Immunotherapy to the Next Level

    After cancer immunotherapy’s initial successes, new challenges are being confronted

    April 1, 2017| Arthur N. Brodsky, PhD
  • AACR17: Immunotherapy’s Impact on the Future of Cancer Treatment

    Dozens of CRI scientists to highlight the latest immunotherapy breakthroughs during five-day conference in nation’s capital.

    March 31, 2017| Arthur N. Brodsky, PhD
  • Financing Better Cancer Treatments

    Inlanta Mortgage again chose CRI to be the beneficiary at their annual conference raffle.

    March 26, 2017| CRI Staff
  • Therese B

    Thèrése B’s Immunotherapy Story

    Melanoma I’m amazed I’m still alive because I know how terrible a disease it is. Thèrése’s Story…
    March 16, 2017| CRI Staff
Previous Page
1 … 66 67 68 69 70 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal